Annual General Meeting

Information about the 2019 Annual General Meeting

Summit Therapeutics held its Annual General Meeting of shareholders at Pewterers’ Hall, Oat Lane, London, EC2V 7DE at 10:00 a.m. on 19 June 2019.

The Notice of Annual General Meeting that contained details of the resolution considered by shareholders at the AGM, the results of the proxy votes lodged by shareholders in advance of the AGM along with the UK Annual Report and Accounts are available below.

Proxy Voting Results
Resolution FOR AGAINST WITHHELD
1 116,570,393 99.86% 157,912 0.14% 11,350
2 90,465,325 83.21% 18,259,674 16.79% 8,014,656
3 116,569,468 99.87% 155,207 0.13% 14,980
4 116,554,880 99.86% 166,907 0.14% 17,868
5 116,512,051 99.82% 208,587 0.18% 19,017
6 116,005,029 99.40% 705,609 0.60% 29,017
7 114,983,012 98.52% 1,722,010 1.48% 34,633
8 114,787,342 98.34% 1,937,735 1.66% 14,578

 

Shareholder Documents